These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2820136)

  • 1. Inhibition of poliovirus uncoating by disoxaril (WIN 51711).
    Zeichhardt H; Otto MJ; McKinlay MA; Willingmann P; Habermehl KO
    Virology; 1987 Sep; 160(1):281-5. PubMed ID: 2820136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disoxaril stabilization and immunogenicity of poliovirus procapsids.
    Rombaut B; Brioen P; Boeyé A
    J Gen Virol; 1990 May; 71 ( Pt 5)():1081-6. PubMed ID: 2161045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibitory effect of enviroxime and disoxaril on poliovirus type 1 replication.
    Nikolaeva L; Galabov AS
    Acta Virol; 1995 Dec; 39(5-6):235-41. PubMed ID: 8722291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
    Fox MP; Otto MJ; McKinlay MA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro assembly of poliovirus 14 S subunits: disoxaril stabilization as a model for the antigenicity conferring activity of infected cell extracts.
    Rombaut B; Boeyé A
    Virology; 1991 Feb; 180(2):788-92. PubMed ID: 1703372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.
    González ME; Almela MJ; Yacout M; Carrasco L
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1259-61. PubMed ID: 2168147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of the synergistic antienteroviral combination of enviroxime and disoxaril.
    Nikolaeva L; Galabov AS
    Acta Virol; 1999 Aug; 43(4):263-5. PubMed ID: 10749374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
    Otto MJ; Fox MP; Fancher MJ; Kuhrt MF; Diana GD; McKinlay MA
    Antimicrob Agents Chemother; 1985 Jun; 27(6):883-6. PubMed ID: 2992365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entry of poliovirus type 1 and Mouse Elberfeld (ME) virus into HEp-2 cells: receptor-mediated endocytosis and endosomal or lysosomal uncoating.
    Zeichhardt H; Wetz K; Willingmann P; Habermehl KO
    J Gen Virol; 1985 Mar; 66 ( Pt 3)():483-92. PubMed ID: 2857762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibitory effects of dual combinations of picornavirus replication inhibitors.
    Nikolaeva L; Galabov AS
    Acta Virol; 1999 Oct; 43(5):303-11. PubMed ID: 10757231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating.
    Diana GD; McKinlay MA; Otto MJ; Akullian V; Oglesby C
    J Med Chem; 1985 Dec; 28(12):1906-10. PubMed ID: 2999407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of poliovirus RNA synthesis by brefeldin A.
    Maynell LA; Kirkegaard K; Klymkowsky MW
    J Virol; 1992 Apr; 66(4):1985-94. PubMed ID: 1312615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
    Dove AW; Racaniello VR
    J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action and capsid-stabilizing properties of VHHs with an in vitro antipolioviral activity.
    Schotte L; Strauss M; Thys B; Halewyck H; Filman DJ; Bostina M; Hogle JM; Rombaut B
    J Virol; 2014 Apr; 88(8):4403-13. PubMed ID: 24501405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of 3-methylquercetin on poliovirus RNA replication.
    Castrillo JL; Carrasco L
    J Virol; 1987 Oct; 61(10):3319-21. PubMed ID: 2442414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipoliovirus activity and mechanism of action of 3-methylthio-5-phenyl-4-isothiazolecarbonitrile.
    Garozzo A; Stivala A; Tempera G; Castro A
    Antiviral Res; 2010 Dec; 88(3):325-8. PubMed ID: 20955736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipoliovirus activity of isothiazole derivatives: mode of action of 5,5'-diphenyl-3,3'-diisothiazole disulfide (DID).
    Garozzo A; Pinizzotto MR; Guerrera F; Tempera G; Castro A; Geremia E
    Arch Virol; 1994; 135(1-2):1-11. PubMed ID: 8198435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A.
    Irurzun A; Perez L; Carrasco L
    Virology; 1992 Nov; 191(1):166-75. PubMed ID: 1329315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
    Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
    Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles.
    Almela MJ; González ME; Carrasco L
    J Virol; 1991 May; 65(5):2572-7. PubMed ID: 1850030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.